Clinical Trial Update: Treatment of Symptomatic Lumbar Internal Disc Disruption (IDD) With the Biostat® System [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the Biostat System for symptomatic lumbar internal disc disruption was terminated, and the results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease
• Internal Disc Disruption
• Low Back Pain

Drugs mentioned

• Biostat System

Snippet

Sponsor: Spinal Restoration, Inc. | Conditions: Back Pain, Chronic Low Back Pain | Phase 3 | Status: TERMINATED | Results posted: 2014-05-05